Therapies and Therapeutics
The evolution of resistant strains is a natural phenomenon which occurs once microorganisms replicate themselves or when resistant traits are exchanged between them. The use and misuse of antimicrobial drugs enhances the emergence of drug-resistant strains. Designing safe and effective drugs specifically antiviral is difficult, because viruses use the host's cells to replicate. Recent reports showed that infection in human can occur by close contact with pets (dogs and cats). As cultural detection of some bacteria like Arcobacter is time consuming and not confirmatory, various DNA based protocols have been developed for rapid and accurate identification of Arcobacter species. phenotypic methods have been described for typing bacteria (including bio typing, serotyping and phage typing schemata), in the case of phage- and serotyping schemes, not widely available. Molecular epidemiology is the understanding of the pathogenesis of disease by identifying specific pathways, genes and molecules that influence the risk of developing disease. Reverse Zoonosis refers to Infectious diseases that are found in humans which can be transmitted to animals. Bacteria and viruses that are deadly to one type of creature can evolve quickly to infect another. Increasing human population, travel, and the global food business increase the likelihood that viruses will jump from animals into humans, the same factors ensure the reverse spread as well – often with dire consequences for zoological parks and wild and domestic animals. Hence the central element of modern technology treatment is the Nano patch™ array itself which consists of a 1 cm2 square of silicon with ~20,000 micro projections on its surface - invisible to the naked eye.
- Anti biotics
- Anti microbials
- Anti inflammatory drugs and NSAIDS
- Anti septics
- Vaccines and vaccination
- Chemotherapy
- Traditional medicines
- Herbal treatment
- Interventional agents
- Biopharmaceutical products
Related Conference of Therapies and Therapeutics
9th International Conference on Antimicrobial and Antibacterial Agents
10th International Conference on Microbiome, Probiotics & Gut Nutrition
9th International Conference on Clinical Microbiology, Virology and Infectious Diseases
22nd International Conference on Microbial Interactions & Microbial Ecology
13th International Congress on Trauma, Critical Care and Emergency Medicine
Therapies and Therapeutics Conference Speakers
Recommended Sessions
- Clinical Microbiology
- Diagnostic Microbiology: Applications
- Diagnostic Techniques and Technology: Healthcare
- Improving Infectious Disease Surveillance
- Improving Public Health Practice
- Infectious Diseases & Food Microbiology
- Infectious Diseases in Animals
- Infectious Diseases in Plants
- Infectious Diseases: Prevention and treatment
- Mechanism and Immunology of Diseases
- Microbial Chemistry of Infectious Diseases
- Microbial Vaccines and Drugs
- Microbiology: An evolving Science
- Pathogens of Infectious Diseases
- Therapies and Therapeutics
- Types of Infectious Diseases
Related Journals
Are you interested in
- Advances in Bacteriology and Microbiology - Bacteriology-2026 (UAE)
- Agricultural Microbiology & Plant–Microbe Interactions - Beneficial Microbes 2027 (UK)
- Animals in a Bacterial World-A New Imperative for the Life Sciences - Microbiome 2026 (USA)
- Antimicrobial Resistance and Antibiotic Alternatives - Bacteriology-2026 (UAE)
- Arbuscular Mycorrhizal Fungi (AMF) - Microbiome 2026 (USA)
- Bacterial and Microbial Genomics & Proteomics - Bacteriology-2026 (UAE)
- Bacterial Selection for Biological Control of Plant Disease - Microbiome 2026 (USA)
- Biofilms & Microbial Surface Interactions - Beneficial Microbes 2027 (UK)
- Bioinformatics and Microbial Data Science - Bacteriology-2026 (UAE)
- Biostimulants and Biocontrol Strategies - Microbiome 2026 (USA)
- Clinical Microbiology and Infectious Diseases - Bacteriology-2026 (UAE)
- Computational and AI-driven Microbiology - Bacteriology-2026 (UAE)
- Critical Care Medicine - TRAUMA 2027 (France)
- Emergency Nursing and Trauma Care - TRAUMA 2027 (France)
- Environmental Microbiology and Bioremediation - Bacteriology-2026 (UAE)
- Ethics, Legal, and Policy Issues in Critical Care - TRAUMA 2027 (France)
- Extremophiles & Microbial Adaptation - Beneficial Microbes 2027 (UK)
- Food Microbiology and Safety - Bacteriology-2026 (UAE)
- Global Health and Trauma Care - TRAUMA 2027 (France)
- Harnessing Phytomicrobiome Signaling for Microbiome Engineering - Microbiome 2026 (USA)
- Industrial Microbiology and Biotechnology - Bacteriology-2026 (UAE)
- Interplay Between Diet, Gut Microbiota, Epigenetic Events and Colorectal Cancer - Microbiome 2026 (USA)
- Marine Microbiology & Microbial Resources - Beneficial Microbes 2027 (UK)
- Medical and Pharmaceutical Microbiology - Bacteriology-2026 (UAE)
- Microbial Biomanufacturing & Bioeconomy - Beneficial Microbes 2027 (UK)
- Microbial Biomaterials & Bio-Based Products - Beneficial Microbes 2027 (UK)
- Microbial Communication & Quorum Sensing - Beneficial Microbes 2027 (UK)
- Microbial Diagnostics & Advanced Detection Technologies - Beneficial Microbes 2027 (UK)
- Microbial Ecology & Community Interactions - Beneficial Microbes 2027 (UK)
- Microbial Ecology and Evolution - Bacteriology-2026 (UAE)
- Microbial Enzymes & Biocatalysis - Beneficial Microbes 2027 (UK)
- Microbial Enzymes and Metabolites - Bacteriology-2026 (UAE)
- Microbial Evolution & Adaptive Biology - Beneficial Microbes 2027 (UK)
- Microbial Fermentation & Bioprocess Development - Beneficial Microbes 2027 (UK)
- Microbial Metabolites & Bioactive Compounds - Beneficial Microbes 2027 (UK)
- Microbial Pathogenesis and Host Interactions - Bacteriology-2026 (UAE)
- Microbial Resources & Culture Collections - Beneficial Microbes 2027 (UK)
- Microbiome and Human Health - Bacteriology-2026 (UAE)
- Microbiome as a Human Organ - Microbiome 2026 (USA)
- Microbiome- Science Comes to Life - Microbiome 2026 (USA)
- Modulation of Microbiota - Microbiome 2026 (USA)
- One Health & Microbial Interactions - Beneficial Microbes 2027 (UK)
- Pediatric and Neonatal Emergency Care - TRAUMA 2027 (France)
- Pediatric Microbiome-Vaginal Delivery vs C-Section - Microbiome 2026 (USA)
- Plant Beneficial Microbes - Microbiome 2026 (USA)
- Plant Conditioners (Biostimulants) - Microbiome 2026 (USA)
- Resuscitation and Emergency Response - TRAUMA 2027 (France)
- Role of Microbial Communities in Periodontal Diseases and Caries (Oral Microbiome) - Microbiome 2026 (USA)
- Signaling in the PhytoMicrobiome - Microbiome 2026 (USA)
- Skincare Products with Probiotics-Worth the Hype? - Microbiome 2026 (USA)
- Synthetic and Systems Microbiology - Bacteriology-2026 (UAE)
- The Gut Microbiota - Centerpiece of Human Health - Microbiome 2026 (USA)
- The Microbiome as a Therapeutic Target for Metabolic Diseases - Microbiome 2026 (USA)
- The Microbiome in Cancer Development and Therapy - Microbiome 2026 (USA)
- The Microbiota in Early Life Shapes the Immune System - Microbiome 2026 (USA)
- The Skin Microbiome - Microbiome 2026 (USA)
- Trauma and Emergency Medicine - TRAUMA 2027 (France)
- Trauma Imaging and Diagnostics - TRAUMA 2027 (France)
- Trauma Rehabilitation and Recovery - TRAUMA 2027 (France)

